// App-Quantinova.ai

P2-18-01 : Single modality adjuvant therapy with radiation (RT) alone or endocrine therapy (ET) alone in women ≥65 years with early stage, hormone receptor positive breast cancer treated with breast-conserving surgery: A population-based analysis

Researchers

Presenter

  • Mira Goldberg

Principal Investigators

  • Rinku Sutradhar

  • Lawrence Paszat

  • Timothy Whelan

  • Sumei Gu

  • Cindy Fong

  • Eileen Rakovitch

Medical Centers

  • Juravinski Cancer Centre and McMaster University, Hamilton, ON, Canada

  • OICR, Toronto, ON, Canada

  • Sunnybrook Health Sciences Center and University of Toronto, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved